S&P 500
(0.25%) 5 321.41 points
Dow Jones
(0.17%) 39 873 points
Nasdaq
(0.22%) 16 833 points
Oil
(-0.25%) $79.06
Gas
(-1.35%) $2.64
Gold
(-0.02%) $2 425.30
Silver
(0.47%) $32.23
Platinum
(-0.08%) $1 060.10
USD/EUR
(0.01%) $0.921
USD/NOK
(0.04%) $10.66
USD/GBP
(-0.02%) $0.787
USD/RUB
(0.30%) $90.50

实时更新: Invivyd, Inc. [IVVD]

交易所: NASDAQ Global Market 部门: Healthcare 工业: Biotechnology
BUY
66.67%
return -3.00%
SELL
16.67%
return 14.38%
最后更新时间22 May 2024 @ 04:00

-1.78% $ 2.21

购买 139950 min ago

@ $4.03

发出时间: 15 Feb 2024 @ 04:29


回报率: -45.16%


上一信号: Feb 14 - 03:11


上一信号: 出售


回报率: 1.26 %

Live Chart Being Loaded With Signals

Commentary (22 May 2024 @ 04:00):

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States...

Stats
今日成交量 263 386
平均成交量 687 759
市值 263.69M
EPS $0 ( 2024-05-09 )
下一个收益日期 ( $-0.370 ) 2024-08-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.180
ATR14 $0.00300 (0.14%)
Insider Trading
Date Person Action Amount type
2024-01-24 Green Julie Buy 240 000 Stock Option (Right to Buy)
2024-01-24 Green Julie Sell 110 700 Stock Option (Right to Buy)
2024-01-24 Green Julie Sell 97 500 Stock Option (Right to Buy)
2024-01-24 Green Julie Sell 160 000 Stock Option (Right to Buy)
2024-01-19 Adimab, Llc Sell 5 000 000 Common Stock
INSIDER POWER
6.69
Last 36 transactions
Buy: 9 419 589 | Sell: 5 442 000

音量 相关性

長: -0.27 (neutral)
短: -0.95 (very strong negative)
Signal:(30.491) Neutral

Invivyd, Inc. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Invivyd, Inc. 相关性 - 货币/商品

The country flag -0.06
( neutral )
The country flag -0.03
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.33
( neutral )

Invivyd, Inc. 财务报表

Annual 2023
营收: $0
毛利润: $-2.03M (0.00 %)
EPS: $-1.810
FY 2023
营收: $0
毛利润: $-2.03M (0.00 %)
EPS: $-1.810
FY 2022
营收: $0
毛利润: $-462 000 (0.00 %)
EPS: $-2.17
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-5.32

Financial Reports:

No articles found.

Invivyd, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Invivyd, Inc.

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。